CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients

Introduction: Up to now,reliable results regarding the efficacy of anti-SARS-CoV-2 vaccines in patients with multiple myeloma (MM), especially under current myeloma-directed therapy, are scarcely available. Here, we report an analysis describing the level of post-vaccination antibody titers after th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghandili, Susanne, Schönlein, Martin, Becher, Heiko, Wiessner, Christian, Lütgehetmann, Marc, Schulze zur Wiesch, Julian, Bokemeyer, Carsten, Sinn, Marianne, Leypoldt, Lisa, Weisel, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
652.Multiple Myeloma and Plasma cell Dyscrasias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701540/
http://dx.doi.org/10.1182/blood-2021-149062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701540/
http://dx.doi.org/10.1182/blood-2021-149062

Ejemplares similares